Citadel Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $137M | Sell |
297,500
-168,600
| -36% | -$85.3M | 0.02% | 631 |
|
|
2025
Q4 | $264M | Buy |
466,100
+132,000
| +40% | +$70.3M | 0.04% | 380 |
|
|
2025
Q3 | $149M | Buy |
334,100
+88,500
| +36% | +$42.5M | 0.02% | 622 |
|
|
2025
Q2 | $133M | Sell |
245,600
-25,900
| -10% | -$13.5M | 0.02% | 580 |
|
|
2025
Q1 | $134M | Buy |
271,500
+9,800
| +4% | +$5.42M | 0.03% | 534 |
|
|
2024
Q4 | $137M | Sell |
261,700
-99,400
| -28% | -$51.8M | 0.02% | 567 |
|
|
2024
Q3 | $177M | Buy |
361,100
+41,600
| +13% | +$19.4M | 0.03% | 411 |
|
|
2024
Q2 | $142M | Sell |
319,500
-237,700
| -43% | -$94.7M | 0.03% | 493 |
|
|
2024
Q1 | $222M | Buy |
557,200
+119,600
| +27% | +$45.2M | 0.04% | 328 |
|
|
2023
Q4 | $148M | Buy |
437,600
+90,900
| +26% | +$27.1M | 0.03% | 479 |
|
|
2023
Q3 | $101M | Buy |
346,700
+81,400
| +31% | +$25.4M | 0.02% | 620 |
|
|
2023
Q2 | $90.7M | Sell |
265,300
-30,900
| -10% | -$9.35M | 0.02% | 665 |
|
|
2023
Q1 | $75.7M | Sell |
296,200
-184,500
| -38% | -$45.5M | 0.02% | 777 |
|
|
2022
Q4 | $128M | Sell |
480,700
-209,300
| -30% | -$51M | 0.03% | 527 |
|
|
2022
Q3 | $129M | Sell |
690,000
-315,700
| -31% | -$67.8M | 0.03% | 477 |
|
|
2022
Q2 | $202M | Buy |
1,005,700
+379,500
| +61% | +$89M | 0.05% | 279 |
|
|
2022
Q1 | $189M | Sell |
626,200
-562,900
| -47% | -$164M | 0.04% | 369 |
|
|
2021
Q4 | $427M | Sell |
1,189,100
-196,900
| -14% | -$67.7M | 0.09% | 141 |
|
|
2021
Q3 | $459M | Buy |
1,386,000
+144,000
| +12% | +$48.4M | 0.1% | 132 |
|
|
2021
Q2 | $381M | Buy |
1,242,000
+367,500
| +42% | +$103M | 0.09% | 137 |
|
|
2021
Q1 | $215M | Buy |
874,500
+129,900
| +17% | +$32.7M | 0.05% | 264 |
|
|
2020
Q4 | $203M | Sell |
744,600
-224,700
| -23% | -$55.8M | 0.05% | 256 |
|
|
2020
Q3 | $229M | Buy |
969,300
+89,700
| +10% | +$20.1M | 0.07% | 164 |
|
|
2020
Q2 | $167M | Sell |
879,600
-273,900
| -24% | -$49.1M | 0.06% | 227 |
|
|
2020
Q1 | $190M | Sell |
1,153,500
-479,100
| -29% | -$87.7M | 0.09% | 145 |
|
|
2019
Q4 | $322M | Sell |
1,632,600
-17,700
| -1% | -$3.31M | 0.14% | 92 |
|
|
2019
Q3 | $297M | Buy |
1,650,300
+555,900
| +51% | +$96.2M | 0.14% | 87 |
|
|
2019
Q2 | $191M | Sell |
1,094,400
-162,900
| -13% | -$27.9M | 0.09% | 171 |
|
|
2019
Q1 | $239M | Buy |
1,257,300
+1,800
| +0.1% | +$320K | 0.12% | 109 |
|
|
2018
Q4 | $200M | Sell |
1,255,500
-753,300
| -38% | -$128M | 0.11% | 120 |
|
|
2018
Q3 | $384M | Buy |
2,008,800
+666,900
| +50% | +$118M | 0.17% | 66 |
|
|
2018
Q2 | $214M | Buy |
1,341,900
+58,500
| +5% | +$8.92M | 0.11% | 139 |
|
|
2018
Q1 | $177M | Sell |
1,283,400
-654,900
| -34% | -$91.4M | 0.1% | 152 |
|
|
2017
Q4 | $236M | Sell |
1,938,300
-177,600
| -8% | -$22.2M | 0.14% | 111 |
|
|
2017
Q3 | $246M | Buy |
2,115,900
+873,000
| +70% | +$95.1M | 0.19% | 65 |
|
|
2017
Q2 | $129M | Buy |
1,242,900
+515,700
| +71% | +$49.6M | 0.11% | 163 |
|
|
2017
Q1 | $61.9M | Sell |
727,200
-27,000
| -4% | -$2.13M | 0.06% | 351 |
|
|
2016
Q4 | $53.1M | Buy |
754,200
+60,300
| +9% | +$4.43M | 0.05% | 358 |
|
|
2016
Q3 | $55.9M | Sell |
693,900
-166,500
| -19% | -$12.7M | 0.06% | 338 |
|
|
2016
Q2 | $63.2M | Buy |
860,400
+55,800
| +7% | +$3.93M | 0.07% | 255 |
|
|
2016
Q1 | $53.7M | Sell |
804,600
-451,800
| -36% | -$28M | 0.07% | 274 |
|
|
2015
Q4 | $76.2M | Sell |
1,256,400
-198,900
| -14% | -$11.2M | 0.08% | 258 |
|
|
2015
Q3 | $74.3M | Buy |
1,455,300
+252,900
| +21% | +$14.3M | 0.07% | 275 |
|
|
2015
Q2 | $64.7M | Buy |
1,202,400
+67,500
| +6% | +$3.78M | 0.06% | 387 |
|
|
2015
Q1 | $63.7M | Sell |
1,134,900
-142,200
| -11% | -$8.05M | 0.06% | 377 |
|
|
2014
Q4 | $75.1M | Buy |
1,277,100
+65,700
| +5% | +$3.66M | 0.07% | 295 |
|
|
2014
Q3 | $62.2M | Buy |
1,211,400
+216,900
| +22% | +$10.8M | 0.07% | 328 |
|
|
2014
Q2 | $45.5M | Sell |
994,500
-243,000
| -20% | -$10.7M | 0.05% | 421 |
|
|
2014
Q1 | $60.2M | Sell |
1,237,500
-95,400
| -7% | -$4.49M | 0.07% | 329 |
|
|
2013
Q4 | $56.9M | Sell |
1,332,900
-142,200
| -10% | -$5.98M | 0.07% | 310 |
|
|
2013
Q3 | $61.7M | Buy |
1,475,100
+347,400
| +31% | +$15.3M | 0.09% | 228 |
|
|
2013
Q2 | $63.5M | Buy |
+1,127,700
| New | +$62.1M | 0.11% | 201 |
|
Other funds holding ISRG
VCM
VPM
Citadel Advisors's ISRG Position: Q1 2026 in Review
Citadel Advisors increased its Intuitive Surgical (ISRG) stake by 30% in Q1 2026, buying an estimated $160M and bringing the position to 1,356,011 shares worth $625M. The position accounts for 0.1% of the portfolio, ranked #140.
Citadel Advisors first reported a position in ISRG in Q2 2013 and has held it in 49 quarters since. The position peaked at $664M in Q2 2023. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Citadel Advisors held 1,356,011 shares of Intuitive Surgical worth $625M as of Q1 2026.
- Citadel Advisors bought 315,444 Intuitive Surgical shares in Q1 2026, an estimated $160M.
- Intuitive Surgical made up 0.1% of Citadel Advisors's portfolio in Q1 2026, its #140 holding.
- Citadel Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Intuitive Surgical position peaked at $664M in Q2 2023.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.